monomethyl fumarate

DRUG2 trials

Sponsors

Banner Life Sciences LLC

Conditions

Relapsing Remitting Multiple Sclerosis

Unknown Phase

Observational Study in Patients With Relapsing-Remitting Multiple Sclerosis Switched to Bafiertam® From Dimethyl Fumarate

WithdrawnNCT04925778

Banner Life Sciences LLCRelapsing Remitting Multiple Sclerosis

Start: 2021-06-30End: 2022-09-29Updated: 2021-11-18

Observational Study of Persistence on Bafiertam Treatment in Routine Clinical Practice

TerminatedNCT05978531

Banner Life Sciences LLCRelapsing Remitting Multiple Sclerosis

Start: 2023-08-17End: 2025-02-24Updated: 2025-03-06